ASKC141

1. To investigate the consistency of the in vivo PK characteristics of dextrorotatory lipoic acid after a single administration of dextrorotatory lipoic acid tromethamine injection and lipoic acid injection, using lipoic acid injection as a control. 2. To obtain the pharmacokinetic parameters of dextrorotatory lipoic acid tromethamine injection in healthy Chinese subjects after a single administration, to provide a basis for the dosage of subsequent clinical trials. 3. To evaluate the safety of dextrorotatory lipoic acid tromethamine injection in healthy Chinese subjects after a single administration.

1. To evaluate the tolerability and safety of different doses of single administration of dextrolipoic acid tromethamine injection in healthy Chinese subjects; 2. To evaluate the tolerability and safety of dextrolipoic acid tromethamine injection in healthy Chinese subjects after multiple administrations; 3. To obtain the pharmacokinetic (PK) parameters of dextrolipic acid in healthy Chinese subjects after single/multiple administrations of dextrolipoic acid tromethamine injection, and provide a basis for the selection of dosage in subsequent clinical trials.